Matches in Wikidata for { <http://www.wikidata.org/entity/Q106138902> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q106138902 description "clinical trial" @default.
- Q106138902 description "ensayo clínico" @default.
- Q106138902 description "ensayu clínicu" @default.
- Q106138902 description "klinisch onderzoek" @default.
- Q106138902 description "клінічне випробування" @default.
- Q106138902 description "կլինիկական փորձարկում" @default.
- Q106138902 description "临床试验" @default.
- Q106138902 name "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease" @default.
- Q106138902 name "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease" @default.
- Q106138902 type Item @default.
- Q106138902 label "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease" @default.
- Q106138902 label "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease" @default.
- Q106138902 prefLabel "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease" @default.
- Q106138902 prefLabel "A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease" @default.
- Q106138902 P1132 Q106138902-2D283712-3777-4C21-B2E6-F89F484DCDC4 @default.
- Q106138902 P1476 Q106138902-666B0259-91D7-4E35-B285-AFC132AAF2B4 @default.
- Q106138902 P2899 Q106138902-36BB552F-5136-41FE-938C-C54ACAF70B0B @default.
- Q106138902 P3098 Q106138902-78FFFBAC-473A-4198-B8FA-2C5F31DE30C3 @default.
- Q106138902 P31 Q106138902-A1198D11-CA7F-4BA2-9D29-EF148EB6ECD3 @default.
- Q106138902 P4135 Q106138902-66DC0B9F-0A1F-4C0C-B620-BA0AEF5E3860 @default.
- Q106138902 P4844 Q106138902-4CA0862E-27B5-405C-AE98-BD6D0E5DDBD0 @default.
- Q106138902 P580 Q106138902-A321A936-7258-4F4A-8CA1-5179ECE16114 @default.
- Q106138902 P582 Q106138902-34FD3027-C0CC-43D9-A0D4-8195988CA7DD @default.
- Q106138902 P6099 Q106138902-E2C35903-10D1-40FD-BD77-B8DF192EEAE1 @default.
- Q106138902 P8005 Q106138902-ED6D81A3-C67A-42B3-B82C-A66D058BD72F @default.
- Q106138902 P8363 Q106138902-03C3FEA1-0C86-474F-9CAD-34E33AF6F5AC @default.
- Q106138902 P921 Q106138902-E94A950E-5B95-40F9-893D-1DCE0EA8F80F @default.
- Q106138902 P1132 "+120" @default.
- Q106138902 P1476 "A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy" @default.
- Q106138902 P2899 "+2" @default.
- Q106138902 P3098 "NCT04779320" @default.
- Q106138902 P31 Q30612 @default.
- Q106138902 P4135 "+17" @default.
- Q106138902 P4844 Q7918002 @default.
- Q106138902 P580 "2021-04-17T00:00:00Z" @default.
- Q106138902 P582 "2024-11-30T00:00:00Z" @default.
- Q106138902 P6099 Q42824827 @default.
- Q106138902 P8005 Q76649614 @default.
- Q106138902 P8363 Q78089383 @default.
- Q106138902 P921 Q701216 @default.